Abstract: A method of promoting or improving the feed efficiency and the muscle to fat ratio livestock animal by administering to the animal a therapeutically effective amount of a pure or substantially pure RR-enantiomer of ractopamine. Also disclosed are animal feed preparations and compositions and pharmaceutical preparations capable of increasing lean meat deposition in an animal or for improving lean meat to fat ratio in an animal or for promoting or improving the growth of an animal or for improving the feed efficiency of an animal, the feed preparation, compositions and pharmaceutical preparations including a therapeutically effective amount of a pure or substantially pure RR-enantiomer of ractopamine.

Abstract: The present invention relates to new tetralin compounds, the methods of preparing said tetralin compounds, the method of using said tetralin compounds as local anesthetics and dermal anesthetics, said compounds having particularly valuable properties as dermal and topical anesthetics in mammals, including man, as well as compositions containing said compounds.

Abstract: A method is disclosed utilizing an optically pure eutomer of salbutamol for reducing body fat and/or body weight in mammals and birds. A food composition including the eutomer is also disclosed.

Abstract: Methods are disclosed using Trospium Chloride, an antimuscarinic smooth muscle relaxant, for the treatment of urinary incontnence, while avoiding the concomitant liability of adverse side effect associated with other antimuscarinic drugs.

Abstract: Methods are disclosed using trospium, an antimuscarinic smooth muscle relaxant, for the treatment of smooth muscle disorders, while avoiding the concomitant liability of adverse side effects associated with conventional antimuscarinic treatment.

Abstract: Methods are disclosed using Trospium Chloride, an antimuscarinic smooth muscle relaxant, for the treatment of urinary incontinence, and other disorders, while avoiding the concomitant liability of adverse side effects associated with conventional antimuscarinic treatment.

Abstract: Methods are disclosed utilizing DCL, a metabolic derivative of loratadine, for the treatment of allergic rhinitis, and other disorders, while avoiding the concomitant liability of adverse side-effects associated with other non-sedating antihistamines.

Abstract: A method is disclosed utilizing an optically pure eutomer of salbutamol for reducing body fat and/or body weight in mammals and birds. A food composition including the eutomer is also disclosed.

Abstract: Methods are disclosed using Trospium Chloride, an antimuscarinic smooth muscle relaxant, for the treatment of urinary incontinence, and other disorders, while avoiding the concomitant liability of adverse side effects associated with other antimuscarinic drugs.